Why the study?
Whether the level of NLRP1 is related to the severity of coronary artery stenosis in patients with coronary artery disease had not been reported.
Is the serum NLRP1 level associated with the severity of coronary artery stenosis in patients with coronary artery disease?
Is the serum NLRP1 level associated with the severity of coronary artery stenosis in patients with coronary artery disease?
Serum NLRP1 levels are elevated in patients with unstable angina and correlate with the severity of coronary artery lesions, suggesting its potential as a biomarker for CAD severity.
Answers are grounded in this paper and cite their sources.
Serum NLRP1 rises with CAD lesion severity in UA; leaves open incremental prognostic value beyond standard markers.
Background: The pathogenesis of coronary artery disease is complex, and inflammation is one of the regulatory factors. The nucleotide-binding oligomerization domain (NOD)-like receptor protein 1 (NLRP1) plays an important role in the cellular inflammatory response, cell apoptosis, cell death, and autoimmune diseases. Whether the level of NLRP1 is related to the severity of coronary artery stenosis in patients with coronary artery disease (CAD) has not been reported. Objective: To test the serum level of NLRP1 in unstable angina (UA) patients and investigate the effect of NLRP1 on coronary stenosis severity of the coronary artery disease (CAD). Methods: 307 patients hospitalized in the Department of Cardiology of the Affiliated Hospital of Xuzhou Medical University for coronary angiography from January 1, 2021, to December 31, 2022 were included. We detect the level of NLRP1 in the serum of the included patients. Patients were divided into UA group and control group according to coronary angiography results and other clinical data. We use logistic regression to screen the influencing factors of UA. Then, subgroups were divided according to the Gensini score and the number of coronary artery lesions, and the difference of serum NLRP1 level between the groups was compared. Spearman correlation analysis was used to explore the correlation between the serum NLRP1 level and Gensini score. We analyze the diagnostic value of NLRP1 for UA by drawing ROC curve. Results: = 50) was 24.75 pg/ml, IQR 13.49, 41.95. Serum NLRP1 levels were significantly different among different subgroups. The patient's Gensini score was correlated with the patient's serum NLRP1 level. Conclusion: The serum NLRP1 level is increased in patients with UA, which is increased with the increasing severity of coronary lesions.
No takes yet. Share an insight, caveat, or question.
Zong et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: